Cidara Therapeutics Inc (CDTX)

Official site

BIOTECHNOLOGY

$221.38

+0.00 (+0.00%)

Last updated: Jan 07, 2026 at 4:00 PM ET

Earnings

Performance (10Y)

Beat Rate

53%(19/36)

Avg Surprise

-27.42%

Period	Reported	Est.	Range	Surprise	B/M	Analysts	Revisions	YoY
Sep 30, 2025Sep 25 Reported Nov 6, 2025Reported Nov 6	$-3.10	$-2.77	$-3.08 - $-2.66	-11.91%	Miss	7	2 0 30d	-26.5%
Jun 30, 2025Jun 25 Reported Aug 7, 2025Reported Aug 7	$-1.65	$-3.04	$-3.54 - $-2.42	+45.72%	Beat	6	2 0 30d	+91.7%
Mar 31, 2025Mar 25 Reported Apr 21, 2025Reported Apr 21	$-1.66	N/A	-	+52.20%	Beat	4	0 3 30d	+27.2%
Dec 31, 2024Dec 24 Reported Mar 7, 2025Reported Mar 7	$-5.38	$-3.67	-	-46.49%	Miss	4	2 0 30d	-13350.0%
Sep 30, 2024Sep 24 Reported Oct 31, 2024Reported Oct 31	$-2.45	$-4.25	$-5.66 - $-1.87	+42.35%	Beat	3	No revisions (30d)	-2622.2%
Jun 30, 2024Jun 24 Reported Aug 13, 2024Reported Aug 13	$-19.99	$-3.22	$-4.10 - $-2.35	-520.81%	Miss	2	0 1 30d	-14178.6%
Mar 31, 2024Mar 24 Reported May 15, 2024Reported May 15	$-2.28	$-0.20	$-0.20 - $-0.20	-1040.00%	Miss	1	No revisions (30d)	-7700.0%
Dec 31, 2023Dec 23 Reported Mar 27, 2024Reported Mar 27	$-0.04	N/A	-	+60.00%	Beat	3	No revisions (30d)	+78.9%
Sep 30, 2023Sep 23 Reported Nov 2, 2023Reported Nov 2	$-0.09	$-0.16	$-0.20 - $-0.11	+43.75%	Beat	4	No revisions (30d)	-152.9%
Jun 30, 2023Jun 23 Reported Aug 3, 2023Reported Aug 3	$-0.14	$-0.13	$-0.19 - $-0.09	-7.69%	Miss	3	No revisions (30d)	+26.3%
Mar 31, 2023Mar 23 Reported May 11, 2023Reported May 11	$0.03	$-0.04	$-0.19 - $0.06	+175.00%	Beat	3	No revisions (30d)	+111.1%
Dec 31, 2022Dec 22 Reported Mar 23, 2023Reported Mar 23	$-0.19	$-0.17	$-0.27 - $-0.04	-11.76%	Miss	3	No revisions (30d)	+26.9%
Sep 30, 2022Sep 22 Reported Nov 3, 2022Reported Nov 3	$0.17	$0.18	$0.12 - $0.30	-5.56%	Miss	3	No revisions (30d)	+145.9%
Jun 30, 2022Jun 22 Reported Aug 9, 2022Reported Aug 9	$-0.19	$-0.28	$-0.29 - $-0.26	+32.14%	Beat	4	No revisions (30d)	-205.6%
Mar 31, 2022Mar 22 Reported May 11, 2022Reported May 11	$-0.27	$-0.29	$-0.37 - $-0.26	+6.90%	Beat	5	No revisions (30d)	+30.8%
Dec 31, 2021Dec 21 Reported Mar 7, 2022Reported Mar 7	$-0.26	$-0.34	$-0.39 - $-0.27	+23.53%	Beat	6	No revisions (30d)	+46.9%
Sep 30, 2021Sep 21 Reported Nov 10, 2021Reported Nov 10	$-0.37	$-0.36	$-0.40 - $-0.32	-2.78%	Miss	6	No revisions (30d)	+9.8%
Jun 30, 2021Jun 21 Reported Aug 12, 2021Reported Aug 12	$0.18	$-0.08	$-0.27 - $0.10	+325.00%	Beat	2	No revisions (30d)	+140.0%
Mar 31, 2021Mar 21 Reported May 13, 2021Reported May 13	$-0.39	$-0.26	$-0.45 - $-0.15	-50.00%	Miss	3	1 0 30d	+15.2%
Dec 31, 2020Dec 20 Reported Feb 25, 2021Reported Feb 25	$-0.49	$-0.24	$-0.43 - $-0.14	-104.17%	Miss	4	No revisions (30d)	-16.7%
Sep 30, 2020Sep 20 Reported Nov 5, 2020Reported Nov 5	$-0.41	$-0.38	$-0.51 - $-0.10	-7.89%	Miss	5	No revisions (30d)	-612.5%
Jun 30, 2020Jun 20 Reported Aug 13, 2020Reported Aug 13	$-0.45	$-0.28	$-0.45 - $-0.02	-60.71%	Miss	5	No revisions (30d)	+8.2%
Mar 31, 2020Mar 20 Reported May 13, 2020Reported May 13	$-0.46	$-0.34	$-0.44 - $-0.20	-35.29%	Miss	5	No revisions (30d)	+23.3%
Dec 31, 2019Dec 19 Reported Mar 4, 2020Reported Mar 4	$-0.42	$-0.43	$-0.65 - $-0.21	+2.33%	Beat	6	No revisions (30d)	+4.5%
Sep 30, 2019Sep 19 Reported Nov 7, 2019Reported Nov 7	$0.08	N/A	-	+130.77%	Beat	6	No revisions (30d)	+116.3%
Jun 30, 2019Jun 19 Reported Aug 8, 2019Reported Aug 8	$-0.49	$-0.57	$-0.65 - $-0.36	+14.04%	Beat	5	No revisions (30d)	+56.6%
Mar 31, 2019Mar 19 Reported May 9, 2019Reported May 9	$-0.60	$-0.60	$-0.70 - $-0.51	+0.00%	Beat	4	No revisions (30d)	+25.0%
Dec 31, 2018Dec 18 Reported Feb 28, 2019Reported Feb 28	$-0.44	$-0.59	-	+25.42%	Beat	4	No revisions (30d)	+36.2%
Sep 30, 2018Sep 18 Reported Nov 8, 2018Reported Nov 8	$-0.49	$-0.60	$-0.66 - $-0.56	+18.33%	Beat	5	No revisions (30d)	+32.9%
Jun 30, 2018Jun 18 Reported Aug 8, 2018Reported Aug 8	$-1.13	$-0.66	$-0.83 - $-0.53	-71.21%	Miss	7	No revisions (30d)	-14.1%
Mar 31, 2018Mar 18 Reported May 10, 2018Reported May 10	$-0.80	$-0.64	$-0.72 - $-0.58	-25.00%	Miss	6	No revisions (30d)	+0.0%
Dec 31, 2017Dec 17 Reported Feb 27, 2018Reported Feb 27	$-0.69	$-0.76	-	+9.21%	Beat	7	No revisions (30d)	+21.6%
Sep 30, 2017Sep 17 Reported Nov 8, 2017Reported Nov 8	$-0.73	$-0.94	$-1.02 - $-0.81	+22.34%	Beat	9	1 0 30d	-
Jun 30, 2017Jun 17 Reported Aug 9, 2017Reported Aug 9	$-0.99	$-0.88	$-0.96 - $-0.76	-12.50%	Miss	7	No revisions (30d)	-
Mar 31, 2017Mar 17 Reported May 10, 2017Reported May 10	$-0.80	$-0.88	-	+9.09%	Beat	-	-	-
Dec 31, 2016Dec 16 Reported Mar 15, 2017Reported Mar 15	$-0.88	$-0.79	-	-11.39%	Miss	-	-	-

Key Metrics

Valuation
P/E Ratio	N/A	EV/EBITDA	N/A
Price/FCF	N/A	FCF Yield	N/A
Profitability
Profit Margin	N/A	Operating Margin	N/A
ROE	N/A	ROIC	N/A
Financial Health
Debt/Equity	N/A	Interest Coverage	N/A
Current Ratio	N/A	Quick Ratio	N/A
Trading Statistics
Beta	N/A	Avg Volume	N/A
52-Week High	N/A	52-Week Low	N/A

Technical Indicators Dashboard

Moving Averages

SMA 10$220.97

SMA 20$220.65

SMA 50$187.66

SMA 200N/A

EMA 10$220.93

EMA 20$217.54

EMA 50$190.30

EMA 200$107.76

MACD

Line: 7.50Signal: 10.27Hist: -2.77

ADX

ADX: 73.4+DI: 53.8-DI: 8.5

Aroon & PSAR

Aroon Up92.0

Aroon DownN/A

PSAR$218.87

Bollinger Bands

Upper Band$221.60

Lower Band$219.70

%B Position86%(Upper)

Band Width0.89

RSI (14-Day)

Overbought

84.2

Momentum Oscillators

Stoch %K96.2

Stoch %D94.7

Williams %R-2.6

ROC (10d)0.2%

Momentum0.53

CCI (20d)141.8

MFI (14d)73.6

Volatility Measures

ATR (14d)$1.50(0.7%)

StdDev (20d)0.47

Hist Vol2.3%(Low)

Volume Flow

VWAP$221.38

OBV69.3M

AD Line21.9M

CMF (20d)0.234

Volume Metrics

Avg Vol (20d)962.9K

Vol RatioN/A

VWMA (20d)$220.66

Pivot Points

R3$221.60

R2$221.51

R1$221.44

Pivot Point$221.35

S1$221.28

S2$221.19

S3$221.12

Advanced Oscillators

TSI69.94

Ultimate Osc63.9

KST277.47

Financial Data

Quarter	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022
Total Revenue	$0	$0	$0	$-7,490,000	$0	$302,000	$973,000	$-17,131,000	$9.22M	$5.09M	$26.11M	$10.38M
Cost of Revenue	$0	$0	$0	$83.26M	$0	$0	$0	$1.14M	$0	$0	$0	$29,000
Gross Profit	$0	$0	$0	$-7,490,000	$0	$302,000	$973,000	$-17,131,000	$9.22M	$5.09M	$26.11M	$10.38M

Operating Expenses	$88.63M	$27.38M	$25.27M	$44.54M	$17.39M	$96.29M	$9.52M	$1.49M	$13.69M	$11.84M	$23.33M	$27.43M
R&D	$80.53M	$24.82M	$24.60M	$41.20M	$12.43M	$91.54M	$5.92M	$-1,149,000	$10.39M	$8.66M	$18.87M	$21.94M
SG&A	$8.10M	$6.50M	$6.18M	$3.34M	$4.96M	$4.75M	$3.60M	$2.64M	$3.30M	$3.18M	$4.46M	$5.49M
Operating Income	$-88,628,000	$-27,384,000	$-25,269,000	$-52,033,000	$-17,394,000	$-95,984,000	$-8,542,000	$-18,625,000	$-4,468,000	$-6,748,000	$2.78M	$-17,052,000

Interest Income	$5.39M	$1.67M	$1.90M	$1.81M	$1.86M	$1.77M	$365,000	$527,000	$613,000	$623,000	$232,000	$162,000
Interest Expense	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Income Before Tax	$-83,233,000	$-25,718,000	$-23,480,000	$-50,220,000	$-15,535,000	$-94,210,000	$-8,177,000	$-18,098,000	$-3,855,000	$-6,125,000	$3.01M	$-16,890,000
Income Tax Expense	$0	$0	$0	$0	$0	$0	$0	$0	$-32,000	$40,000	$0	$0

Net Income	$-83,233,000	$-25,718,000	$-23,480,000	$-52,307,000	$-15,985,000	$-91,209,000	$-10,326,000	$-3,213,000	$-9,107,000	$-13,624,000	$3.01M	$-17,162,000

EBITDA	$-88,766,000	$-27,357,000	$-25,330,000	$-51,974,000	$-17,333,000	$-95,759,000	$-8,470,000	$-18,562,000	$-4,433,000	$-7,158,000	$3.29M	$-18,795,000
EBIT	$-88,628,000	$-27,384,000	$-25,379,000	$-52,033,000	$-17,394,000	$-95,984,000	$-8,542,000	$-18,625,000	$-4,468,000	$-6,748,000	$2.78M	$-17,052,000

* Some calculated fields are derived from available data when not provided by source

Related GNG Research

No research available

Be the first to write about CDTX

News

CDTX Price Today: Cidara Therapeutics, Inc. Stock Price, Quote & Chart | MEXC

This article provides current and historical stock price information for Cidara Therapeutics, Inc. (CDTX), listed on NASDAQ. It details key market data, company information...

MEXC•Sep 11, 2026 11:33 AM ET9/11/26•Neutral

Merck hikes revenue outlook as new drug sales grow, but cuts profit guidance due to deal charges

Merck cut its profit guidance due to a charge tied to its acquisition of biotech company Terns Pharmaceuticals.

CNBC•Aug 4, 2026 6:34 AM ET8/4/26•Neutral

CDTX Competitors

Company	Ticker
Pulse Biosciences Inc	PLSE
Viking Therapeutics Inc	VKTX
Legend Biotech Corp	LEGN
CareDx Inc	CDNA
Veracyte Inc	VCYT
Tarsus Pharmaceuticals Inc	TARS
iRhythm Technologies Inc	IRTC
Xenon Pharmaceuticals Inc	XENE

Sector: Healthcare

CDTX Earnings: Beat Rate and Next Report

Beat rate: 4 of 8 quarters (50.0%)
Average surprise: -177.4%

Frequently Asked Questions About CDTX

Does CDTX pay dividends?

Cidara Therapeutics Inc (CDTX) does not currently pay a regular dividend.

Get full access to GNG Research

Create a free account to access portfolio tracking, advanced tools, and more.

Create Free Account Log In